Logo

BMS

Tempus, Bristol Myers Squibb Expand Cancer Biomarker Alliance

Tempus has been providing Bristol Myers Squibb with de-identified transcriptomic datasets to help in the identification of new cancer biomarkers.

Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials

Invitae is working with Bristol Myers Squibb, Janssen, Novartis, and Genentech to advance an NGS panel to gauge the efficacy of AML treatments in trials.

Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan

The firm also provided preliminary revenues of $950 million for Q4 and reinstated guidance of $3.79 billion to $3.88 billion for 2021.

Grail Inks Deals With Amgen, AstraZeneca, Bristol Myers Squibb for MRD Test Development

The company aims to use the methylation technology from its multi-cancer screening assay to detect minimal residual disease in early-stage cancer patients.

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients.

Dec 7, 2020

UK Biobank Collaborating With Biopharmas to Profile Plasma Proteome of 53K Subjects

Nov 5, 2020

Paradigm4 Moves Into Single-Cell Data, Helps Pharma Address COVID-19
Premium

Aug 10, 2020

T Cell Receptor Repertoire Linked to Anti-PD-1 Therapy Response in Hodgkin Lymphoma

Jul 27, 2020

Oncology Informatics Firm Vidence Emerges to Supply Real-World Clinical, Genomic Data to Researchers
Premium

Jul 15, 2020

ReviveMed, Bristol Myers Squibb to Study Metabolomics for Cancer Immunotherapy

Jun 18, 2020

ArcherDx, Bristol Myers Squibb Partner on Minimal Residual Disease Monitoring

Mar 4, 2020

Pulmonary Fibrosis Foundation, Celgene Form Biomarker Consortium

Jan 22, 2020

B Cell Gene Expression Profiling May Enable Cancer Immunotherapy CDx Test
Premium

Dec 9, 2019

PAK4 Inhibition Increases Anti-PD-1 Response in Mouse Models Prompting Phase I Trial

Mar 13, 2019

Quantabio Pairs Rapid Thermal Cycler, Proprietary Reagents for Fast NGS Library QC
Premium

Mar 12, 2019

Biocartis Inks Cancer CDx Deal With Bristol-Myers Squibb

Dec 18, 2018

Bristol-Myers Squibb, Boston Medical Center Partner to Study Immuno-Oncology Response, Resistance

Dec 17, 2018

Bristol-Myers Squibb, H3 Biomedicine Form Cancer Immunotherapy Alliance

Oct 30, 2018

Precision Oncology Highlights From ESMO 2018

Oct 9, 2018

PGDx Liquid Biopsy Assay to be Used in Cancer Drug Study

Sep 13, 2018

Bristol-Myers Squibb to Use Natera's Cell-Free DNA Assay in Immunotherapy Study

May 23, 2018

Two Initiatives Seek to Harmonize Tumor Mutational Burden Testing
Premium

Apr 17, 2018

At AACR, Immuno-Oncology Clinical Trials Offer Mixed Messages on Predictive Biomarkers
Premium

Apr 13, 2018

Illumina, Bristol-Myers Squibb Partner on Companion Dx Development for Immunotherapy

Feb 28, 2018

As Cancer Immunotherapy Evolves, Challenges Compound for Diagnostic Development
Premium

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.